Copyright
©The Author(s) 2020.
World J Gastroenterol. Oct 28, 2020; 26(40): 6260-6269
Published online Oct 28, 2020. doi: 10.3748/wjg.v26.i40.6260
Published online Oct 28, 2020. doi: 10.3748/wjg.v26.i40.6260
Table 1 Demographic and baseline characteristics, intent-to-treat population
9-12 yr old | 13-16 yr old | All SPMC 1 dose × 2 | All PEG | ||||
n (%) | SPMC ½ dose × 2 | SPMC 1 dose × 2 | PEG | SPMC 1 dose × 2 | PEG | ||
Age (yr), mean (SD) | 10.8 (1.0) | 10.5 (1.2) | 10.4 (1.2) | 15.0 (1.0) | 14.9 (0.9) | 12.8 (2.5) | 12.5 (2.5) |
Female, n (%) | 11 (68.8) | 12 (75.0) | 8 (50.0) | 11 (68.8) | 11 (78.6) | 23 (71.9) | 19 (63.3) |
White race, n (%) | 15 (93.8) | 16 (100) | 11 (68.8) | 15 (93.8) | 14 (100) | 31 (96.9) | 25 (83.3) |
BMI (kg/m2), mean (SD) | 19.0 (4.8) | 20.4 (5.3) | 19.4 (5.2) | 24.9 (7.0) | 23.1 (6.5) | 22.6 (6.5) | 21.1 (6.0) |
- Citation: Cuffari C, Ciciora SL, Ando M, Boules M, Croffie JM. Pediatric bowel preparation: Sodium picosulfate, magnesium oxide, citric acid vs polyethylene glycol, a randomized trial. World J Gastroenterol 2020; 26(40): 6260-6269
- URL: https://www.wjgnet.com/1007-9327/full/v26/i40/6260.htm
- DOI: https://dx.doi.org/10.3748/wjg.v26.i40.6260